IOL Chemicals and Pharmaceuticals granted patent 

IOL Chemicals and Pharmaceuticals Limited has informed that the Controller of Patent, Indian Patent Office, Government of India has granted a Patent for invention entitled "An improved safe process for the preparation of Sartan drugs of Formula I". Valsartan, Losartan, Irbesartan, Olmesartan, Candesartan and other Sartan drugs are a class of medicines known as angiotensin II receptor blocker (ARBs) used to treat high blood pressure and heart failure.

Cipla updates on USFDA inspection at manufacturing facility in Goa

Cipla Ltd had earlier announced regarding the United States Food and Drug Administration (USFDA) inspection of its Goa manufacturing facility, The Company has received a communication from the USFDA that the classification of Company's said facility continues to be as Official Action Indicated ("OAI"). USFDA may continue to withhold product approvals from this facility till the outstanding observations are resolved.

The Company has an ongoing derisking plan in place for new product approvals. The Company will work closely with the USFDA and is committed to address these within the stipulated time.